The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease

Application of Tumor Markers SCC-Ag, CEA, and TPA in Patients with Cervical Precancerous Lesions

(2014) Farah Farzaneh et al.   Asian Pacific Journal of Cancer Prevention

Dynamics of Proinflammatory Cytokine Levels and Their Role in the Development of Local and Systemic Effects during Progressing Cervical Cancer

(2014) T. P. Gening et al.   BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Precision treatment for cancer: Role of prognostic and predictive markers

(2014) Michael J. Duffy et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Interleukin-6 levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome

(2014) Mert Küçük et al.   GYNECOLOGICAL ENDOCRINOLOGY

Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer

(2013) S Mitsunaga et al.   BRITISH JOURNAL OF CANCER

Prognostic value of combined serum biomarkers in predicting outcomes in cervical cancer patients

(2013) Juan Li et al.   CLINICA CHIMICA ACTA

Detection of cervical cancer recurrence during follow-up: A multivariable comparison of 9 frequently investigated serum biomarkers

(2013) Jacob P. Hoogendam et al.   GYNECOLOGIC ONCOLOGY

Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice

(2013) Kotaro Shimura et al.   Journal of Gynecologic Oncology

Prognostic Value of Different Patterns of Squamous Cell Carcinoma Antigen Level for the Recurrent Cervical Cancer

(2013) Bae Kwon Jeong et al.   Cancer Research and Treatment

Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases

(2012) M. Shibuya   JOURNAL OF BIOCHEMISTRY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: Comparison with SCC-Ag level

(2011) Yoo-Young Lee et al.   GYNECOLOGIC ONCOLOGY

Prognostic Value of Pretreatment Carcinoembryonic Antigen After Definitive Radiotherapy With or Without Concurrent Chemotherapy for Squamous Cell Carcinoma of the Uterine Cervix

(2010) Eng-Yen Huang et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Analysis of the Effect of Serum Interleukin-6 (IL-6) and Soluble IL-6 Receptor Levels on Survival of Patients with Colorectal Cancer

(2010) K.-Y. Yeh et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Clinical Value of Serum HMGB1 Levels in Early Detection of Recurrent Squamous Cell Carcinoma of Uterine Cervix: Comparison with Serum SCCA, CYFRA21-1, and CEA Levels

(2009) Xiugui Sheng et al.   CROATIAN MEDICAL JOURNAL

The value of tumor marker and cytokine analysis for the assessment of regional lymph node status in cervical cancer patients

(2008) B. KOTOWICZ et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Serum vascular endothelial growth factor: a prognostic factor in cervical cancer

(2008) Petra L. M. Zusterzeel et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Tumor Angiogenesis

(2008) Robert S. Kerbel   NEW ENGLAND JOURNAL OF MEDICINE

The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: A review of the literature

(2007) Angiolo Gadducci et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY